News tagged with cyclosporine
Ciclosporin
Ciclosporin (INN/BAN) (pronounced /ˌsaɪkləˈspɔrɪn/), cyclosporine (USAN), cyclosporin (former BAN), or cyclosporin A is an immunosuppressant drug widely used in post-allogeneic organ transplant to reduce the activity of the immune system, and therefore the risk of organ rejection. Initially isolated from the fungus Tolypocladium inflatum isolated from a soil sample obtained by Sandoz scientists at Hardangervidda, Norway in 1969, ciclosporin is a cyclic nonribosomal peptide of 11 amino acids and contains a single D-amino acid, which are rarely encountered in nature.
For more information about Ciclosporin, read the full article at
Wikipedia.
This text uses material from Wikipedia and is available under the GNU Free Documentation License.
Immunosuppressant medication may be cost-effective for dry eye syndrome
A topical eye emulsion consisting of cyclosporine (a medication used to reduce transplant rejections or to treat arthritis and psoriasis) may be a cost-effective treatment for dry eye syndrome that does not respond to other ...
Medicine & Health / Diseases, Conditions, Syndromes
Feb 09, 2009 |
5 / 5 (1) |
0
System to deliver organ transplant drug -- without harmful side effects
A new system for delivering a drug to organ transplant patients, which could avoid the risk of harmful side effects, is being developed by scientists at the University of Strathclyde in Glasgow.
Nanotechnology / Bio & Medicine
Jan 26, 2012 |
5 / 5 (1) |
1
